These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3089361)

  • 1. Assessment of oral candidiasis in patients with respiratory disease and efficacy of a new nystatin formulation.
    Thompson PJ; Wingfield HJ; Cosgrove RF; Hughes BO; Turner-Warwick ME
    Br Med J (Clin Res Ed); 1986 Jun; 292(6537):1699-700. PubMed ID: 3089361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis.
    Lyu X; Zhao C; Yan ZM; Hua H
    Drug Des Devel Ther; 2016; 10():1161-71. PubMed ID: 27042008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nystatin pastilles and suspension in the treatment of oral candidosis.
    Millns B; Martin MV
    Br Dent J; 1996 Sep; 181(6):209-11. PubMed ID: 8885454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nystatin and lidocaine pastilles for the local treatment of oral mucositis.
    Silva FC; Marto JM; Salgado A; Machado P; Silva AN; Almeida AJ
    Pharm Dev Technol; 2017 Mar; 22(2):266-274. PubMed ID: 27499389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients.
    Nyst MJ; Perriens JH; Kimputu L; Lumbila M; Nelson AM; Piot P
    Ann Soc Belg Med Trop; 1992 Mar; 72(1):45-52. PubMed ID: 1567268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of the usefulness of nystatin in suspension in the treatment of oral candidiasis].
    Smosarska H; Markwart M
    Czas Stomatol; 1971 May; 24(5):477-80. PubMed ID: 4932728
    [No Abstract]   [Full Text] [Related]  

  • 7. Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis.
    DeGregorio MW; Lee WM; Ries CA
    Cancer; 1982 Dec; 50(12):2780-4. PubMed ID: 6958353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis with nystatin pastilles for HIV-associated oral candidiasis.
    MacPhail LA; Hilton JF; Dodd CL; Greenspan D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(5):470-6. PubMed ID: 8757423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants.
    Mukherjee PK; Chen H; Patton LL; Evans S; Lee A; Kumwenda J; Hakim J; Masheto G; Sawe F; Pho MT; Freedberg KA; Shiboski CH; Ghannoum MA; Salata RA;
    AIDS; 2017 Jan; 31(1):81-88. PubMed ID: 27677161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral sustained release nystatin tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination.
    de Aguiar MM; de Albuquerque RP; Marinho DS; Braga BR; Dornelas CB; Oliveira A; de Sousa VP; Torres SR; Alviano DS; Alviano CS; Cabral LM; Holandino C
    Drug Dev Ind Pharm; 2010 May; 36(5):594-600. PubMed ID: 19954405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of oropharyngeal candidiasis in immunocompetent infants: a randomized multicenter study of miconazole gel vs. nystatin suspension. The Antifungals Study Group.
    Hoppe JE
    Pediatr Infect Dis J; 1997 Mar; 16(3):288-93. PubMed ID: 9076817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole versus nystatin in the treatment of oral candidosis.
    Blomgren J; Berggren U; Jontell M
    Acta Odontol Scand; 1998 Aug; 56(4):202-5. PubMed ID: 9765010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group.
    Flynn PM; Cunningham CK; Kerkering T; San Jorge AR; Peters VB; Pitel PA; Harris J; Gilbert G; Castagnaro L; Robinson P
    J Pediatr; 1995 Aug; 127(2):322-8. PubMed ID: 7636666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative trial of clotrimazole troches and oral nystatin suspension in recipients of renal transplants. Use in prophylaxis of oropharyngeal candidiasis.
    Gombert ME; duBouchet L; Aulicino TM; Butt KM
    JAMA; 1987 Nov; 258(18):2553-5. PubMed ID: 3312658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Streptococcus salivarius K12 with nystatin on oral candidiasis-RCT.
    Hu L; Mao Q; Zhou P; Lv X; Hua H; Yan Z
    Oral Dis; 2019 Sep; 25(6):1573-1580. PubMed ID: 31177581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative trial of oral clotrimazole and nystatin for oropharyngeal candidiasis prophylaxis in orthotopic liver transplant patients.
    Ruskin JD; Wood RP; Bailey MR; Whitmore CK; Shaw BW
    Oral Surg Oral Med Oral Pathol; 1992 Nov; 74(5):567-71. PubMed ID: 1437059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nystatin.
    Witten VH; Katz SI
    Med Clin North Am; 1970 Sep; 54(5):1329-37. PubMed ID: 4919155
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of oral candidiasis: a study to determine the clinical response of sodium benzoate compared with nystatin suspension.
    Moshi AH; Jorgensen AF; Pallangyo K
    AIDS; 1998 Nov; 12(16):2237-8. PubMed ID: 9833873
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized trial comparing ketoconazole and nystatin prophylactic therapy in neutropenic patients.
    Vogler WR; Malcom LG; Winton EF
    Cancer Invest; 1987; 5(4):267-73. PubMed ID: 3664330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin nanoparticles: the topical antimycotic suspension treating oral candidiasis.
    Anwar SK; Elmonaem SNA; Moussa E; Aboulela AG; Essawy MM
    Odontology; 2023 Apr; 111(2):350-359. PubMed ID: 36100802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.